Journals in Medical research

Advances in Integrative Medicine

ISSN: 2212-9588
5 Year impact factor: 1.3
Impact factor: 1.2

Affiliated with the Australasian Integrative Medicine Association (AIMA)Advances in Integrative Medicine (AIMED) is an international peer-reviewed, evidence-based research and review journal that is multi-disciplinary within the fields of Integrative and Complementary Medicine.The journal focuses on rigorous quantitative and qualitative research including systematic reviews, clinical trials and surveys, whilst also welcoming medical hypotheses and clinically-relevant articles and case studies disclosing practical learning tools for the consulting practitioner.By promoting research and practice excellence in the field, and cross collaboration between relevant practitioner groups and associations, the journal aims to advance the practice of IM, identify areas for future research, and improve patient health outcomes.Internation... networking is encouraged through clinical innovation, the establishment of best practice and by providing opportunities for cooperation between organisations and communities.

Subscriptions

Clinical Therapeutics

ISSN: 0149-2918
5 Year impact factor: 3
Impact factor: 3.2

The International Peer-Reviewed Journal of Drug TherapyClinical Therapeutics provides peer-reviewed, rapid publication of recent developments in drug and other therapies as well as in diagnostics, pharmacoeconomics, health policy, treatment outcomes, and innovations in drug and biologics research. In addition Clinical Therapeutics features updates on specific topics collated by expert Topic Editors. Clinical Therapeutics is read by a large international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings. Articles are indexed by all major biomedical abstracting databases.Published articles range from pivotal studies exploring new chemical entities in large, multicenter trials to those exploring repurposing of marketed agents. Additionally, pilot studies; reports that assess drug safety and tolera-bility in all phases of development; new routes of administration and new formulations; pharmacokinetic, bio-availability, and biosimilarity; and changes in practice guidelines and standards, are all of interest for publication. Clinical Therapeutics also understands the importance of strengthening the body of evidence surrounding particular agents through the publication of replication studies, negative trials, and failed trials.Beyond the clinic, we seek reports that examine the real-world implications of therapeutics such as comparative effectiveness and pharmacoeconomics studies as well as work that has implications for health policy. Commentaries, which include perspectives and contemporary issues, are sought to offer a balance of viewpoints and scholarly opinion on a broad array of drug-related topics. Case reports, which remain a vital part of our mission, offer clinically valuable lessons. All manuscripts are peer reviewed by independent clinicians or scientists for clinical relevance, technical accuracy, methodological rigor, clarity, and objectivity using a blind review process.In addition to feature articles published monthly, each issue of Clinical Therapeutics features a specific theme section dedicated to an annual update of a specific topic area. A special guest editor will comprise each update with reviews, commentaries, and original research highlighting what's new or controversial in the topical specialty. Authors are invited to submit manuscripts for consideration in the topic updates, identifying submissions as such in their cover letters. Submissions not selected for the updates will be considered for general publication. Submit your manuscript at https://www.editoria...

Subscriptions

The American Journal of Pathology

ISSN: 0002-9440
5 Year impact factor: 4.8
Impact factor: 4.7

Discoveries in Basic and Translational Pathobiology Full Text Online Access, and More, to Paid Subscribers at http://ajp.amjpathol... American Journal of Pathology, official journal of the American Society for Investigative Pathology, published by Elsevier, Inc., seeks high-quality original research reports, reviews, and commentaries related to the molecular and cellular basis of disease. The editors will consider basic, translational, and clinical investigations that directly address mechanisms of pathogenesis or provide a foundation for future mechanistic inquiries. Examples of such foundational investigations include data mining, identification of biomarkers, molecular pathology, and discovery research. Foundational studies that incorporate deep learning and artificial intelligence are also welcome. High priority is given to studies of human disease and relevant experimental models using molecular, cellular, and organismal approaches.

Subscriptions

Value in Health

ISSN: 1098-3015
5 Year impact factor: 5.6
Impact factor: 4.9

AimsValue in Health aims to be a leading source of new methods, best practice guidelines, and innovative research in the field of health economics and outcomes research (HEOR).Value in Health aims to publish papers that expand the frontiers of HEOR science and have a direct impact on the methods used in HEOR and the evidence on value used in healthcare decision making around the world.Scope Value in Health publishes a wide range of article types that contribute to our aims, including:Original theoretical, conceptual and empirical research in HEOR. Our principal interest is in research that contributes to and extends the way value in healthcare is defined and measured, including (but not limited to):methods for the economic evaluation of drugs and other healthcare technologies; outcomes research to strengthen the methods and evidence available to reflect patient and societal perspectives on effectiveness and value.Innovative and high-impact applications of HEOR methods with interest and relevance beyond the specific country and disease area.Good Practices Reports: Value in Health publishes ISPOR’s Good Practices Reports that identify best and emerging practices in a wide range of areas within HEOR.Systematic Reviews: The Editors welcome systematic reviews of any aspect of HEOR. These should go beyond describing a given body of work by synthesizing and critically reviewing the literature and drawing out lessons for HEOR methods and practice. These papers should review empirical studies consistent with the methods outlined by the Cochrane Collaboration and PRISMA. Health Policy Analyses: Analysis and commentary on health policy issues with global relevance to the pursuit of a world where healthcare is effective, efficient, and affordable for all.The ISPOR journal portfolio consists of Value in Health and Value in Health Regional Issues. For more information and detailed guidance about the article types and formatting requirements for Value in Health, please consult the journal’s Instructions for Authors.

Subscriptions

Value in Health Regional Issues

ISSN: 2212-1099
Impact factor: 1.4

AimsValue in Health Regional Issues aims to be the recognized source for regional advancements in heath economics and outcomes research (HEOR).Value in Health Regional Issues aims to publish papers that apply HEOR methods to examine and measure the impact on health systems, policies, and patient populations. Submitted research must focus on regional populations and regional health policies and demonstrate the broader implications for other regions.ScopeValue in Health Regional Issues publishes a wide range of article types that contribute to our aims, including:Applied Research Using HEOR MethodsEconomic evaluations or impact analyses of healthcare interventions (pharmaceuticals, medical devices, or procedures) that examine the effect of regional health policies on healthcare performance, population health, or social welfare.Health Policy AnalysesArticles that translate knowledge across countries (eg, evaluations between high- and low- and middle-income countries, cross country comparisons, etc) and discuss various aspects of health policy, including pricing and reimbursement issues, the adoption of new health technologies, or policies to encourage “value-based” decision making. Health Equity ResearchResearch that reflects regional experiences using HEOR methods such as distributional or extended cost-effectiveness analysis, checklists for qualitative judgments, simple indicators, or deliberative exercises to incorporate health equity concerns into local resource allocation in decisions.Patient-Ce... ResearchArticles that present research on the development and use of measures for patient-reported outcomes and quality-of-life instruments that express the value of healthcare. Research on patient participation in value-based decision-making processes or health technology assessment are also welcome. These papers should show results or impact on the community perception or changes in procedures or outcomes resulting from patient participation in research and policy making.Scoping and Literature ReviewsReviews that synthesize and summarize the current knowledge on a specific topic or question to identify the main concepts, theories, and evidence gaps within a specific geographic region. These papers review empirical studies consistent with the methods outlined by the Cochrane Collaboration and PRISMA. The ISPOR journal portfolio consists of Value in Health Regional Issues and Value in Health. For more information and detailed guidance about the article types and formatting requirements for Value in Health Regional Issues, please consult the journal’s Instructions for Authors.

Subscriptions

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Medical research

Advances in Integrative Medicine

Clinical Therapeutics

The American Journal of Pathology

Value in Health

Value in Health Regional Issues